Interactions governing the entrapment of anticancer drugs by low-molecular-weight hydrogelator for drug delivery applications

RSC Advances ◽  
2016 ◽  
Vol 6 (24) ◽  
pp. 19751-19757 ◽  
Author(s):  
Siddhi Gupta ◽  
Manish Singh ◽  
Amarendar Reddy M. ◽  
Prabhu S. Yavvari ◽  
Aasheesh Srivastava ◽  
...  

We present the effect of size, charge, and hydrophobicity of anticancer drugs on their drug encapsulation efficacy in anl-alanine-based small-molecule hydrogelator.

Nanoscale ◽  
2021 ◽  
Author(s):  
Sanjay Pal ◽  
Vijay Soni ◽  
Sandeep Kumar ◽  
Somesh K Jha ◽  
Nihal Medatwal ◽  
...  

We present a non-immunogenic, injectable, low molecular weight, amphiphilic hydrogel-based drug delivery system (TB-Gel) that can entrap a cocktail of four front-line antitubercular drugs isoniazid, rifampicin, pyrazinamide, and ethambutol. We...


2009 ◽  
Vol 379 (1) ◽  
pp. 131-138 ◽  
Author(s):  
Ning Li ◽  
Chunyang Zhuang ◽  
Mi Wang ◽  
Xiyang Sun ◽  
Shufang Nie ◽  
...  

Pharmaceutics ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 536
Author(s):  
Helena C. Besse ◽  
Yinan Chen ◽  
Hans W. Scheeren ◽  
Josbert M. Metselaar ◽  
Twan Lammers ◽  
...  

The poor pharmacokinetics and selectivity of low-molecular-weight anticancer drugs contribute to the relatively low effectiveness of chemotherapy treatments. To improve the pharmacokinetics and selectivity of these treatments, the combination of a doxorubicin-glucuronide prodrug (DOX-propGA3) nanogel formulation and the liberation of endogenous β-glucuronidase from cells exposed to high-intensity focused ultrasound (HIFU) were investigated in vitro. First, a DOX-propGA3-polymer was synthesized. Subsequently, DOX-propGA3-nanogels were formed from this polymer dissolved in water using inverse mini-emulsion photopolymerization. In the presence of bovine β-glucuronidase, the DOX-propGA3 in the nanogels was quantitatively converted into the chemotherapeutic drug doxorubicin. Exposure of cells to HIFU efficiently induced liberation of endogenous β-glucuronidase, which in turn converted the prodrug released from the DOX-propGA3-nanogels into doxorubicin. β-glucuronidase liberated from cells exposed to HIFU increased the cytotoxicity of DOX-propGA3-nanogels to a similar extend as bovine β-glucuronidase, whereas in the absence of either bovine β-glucuronidase or β-glucuronidase liberated from cells exposed to HIFU, the DOX-propGA3-nanogels hardly showed cytotoxicity. Overall, DOX-propGA3-nanogels systems might help to further improve the outcome of HIFU-related anticancer therapy.


2008 ◽  
Vol 9 (8) ◽  
pp. 2244-2250 ◽  
Author(s):  
Jiban J. Panda ◽  
Aseem Mishra ◽  
Atanu Basu ◽  
Virander S. Chauhan

2020 ◽  
Vol 9 (2) ◽  
pp. 542 ◽  
Author(s):  
Rezvan Jamaledin ◽  
Concetta Di Natale ◽  
Valentina Onesto ◽  
Zahra Taraghdari ◽  
Ehsan Zare ◽  
...  

The growing demand for patient-compliance therapies in recent years has led to the development of transdermal drug delivery, which possesses several advantages compared with conventional methods. Delivering protein through the skin by transdermal patches is extremely difficult due to the presence of the stratum corneum which restricts the application to lipophilic drugs with relatively low molecular weight. To overcome these limitations, microneedle (MN) patches, consisting of micro/miniature-sized needles, are a promising tool to perforate the stratum corneum and to release drugs and proteins into the dermis following a non-invasive route. This review investigates the fabrication methods, protein delivery, and translational considerations for the industrial scaling-up of polymeric MNs for dermal protein delivery.


2020 ◽  
Vol 3 (5) ◽  
pp. 3099-3113 ◽  
Author(s):  
Subhajit Guria ◽  
Avijit Ghosh ◽  
Priyanka Upadhyay ◽  
Manas kumar Das ◽  
Tanushree Mishra ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document